Douglas Faller

Dr. Douglas Faller is a Chief Medical Officer at Imunon, Inc., a Professor at Boston University and a Scientific Founder at Sapientia Pharmaceuticals, Inc. Dr. Faller was previously employed as a Chief Medical Officer by Skyhawk Therapeutics, Inc., a Global Chief Medical Officer by Oryzon Genomics SA, a Chief Medical & Scientific Officer by Viracta Therapeutics, Inc., a Co-Founder by HemaQuest Pharmaceuticals, Inc., a Faculty Member by Dana-Farber Cancer Institute, Inc., a Professor by Harvard Medical School, an Executive Medical Director by Takeda Farmacéutica España SA, a Faculty Member by The University of California, San Francisco, and a Co-Founder by Viracta Subsidiary, Inc. He received his undergraduate degree from Massachusetts Institute of Technology, a graduate degree from The University of California, San Francisco, a doctorate degree from Harvard University and a doctorate degree from Massachusetts Institute of Technology.